FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099006076> ?p ?o ?g. }

• W3099006076 endingPage "233" @default.
• W3099006076 startingPage "227" @default.
• W3099006076 abstract "Objective Oral PARP inhibitors (PARPi) have dramatically changed the treatment landscape for patients with advanced ovarian cancer. However, a subset of patients discontinue PARPi due to treatment-related fatigue. The current study sought to explore patients' lived experiences with fatigue on PARPi. Methods We conducted individual semi-structured interviews with N = 23 women receiving PARPi for advanced ovarian cancer who reported moderate to severe fatigue. Audiotaped interviews were transcribed and we used thematic analysis to code transcripts for emergent themes. Results Four overarching themes emerged. First, participants described their fatigue as milder than what they experienced on intravenous chemotherapy, but noted it consistently limited their daily activities, including work, and interfered with participation in family and social events. Second, fatigue negatively impacted participants' sense of self and identity. Third, most wanted to continue treatment and believed discontinuing PARPi would lead to a cancer recurrence or death. Finally, many participants reported that their support networks were unaware of their ongoing cancer treatment or the resulting fatigue; a situation that may prove isolating and result in reduced social support. Conclusions Our findings underscore patients' persistent experience of fatigue on PARPi, the impact of fatigue on multiple domains of functioning, and a lack of understanding of side effects resulting from oral maintenance treatments among patients' social networks. Our findings highlight the need for interventions to address treatment-related fatigue to limit the negative impacts of fatigue on ovarian cancer patients' well-being." @default.
• W3099006076 created "2020-11-23" @default.
• W3099006076 creator A5005358622 @default.
• W3099006076 creator A5014584195 @default.
• W3099006076 creator A5032378308 @default.
• W3099006076 creator A5043779387 @default.
• W3099006076 creator A5060953135 @default.
• W3099006076 creator A5079212572 @default.
• W3099006076 creator A5087865806 @default.
• W3099006076 date "2021-01-01" @default.
• W3099006076 modified "2023-10-16" @default.
• W3099006076 title "Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study" @default.
• W3099006076 cites W1548686894 @default.
• W3099006076 cites W1812469610 @default.
• W3099006076 cites W1852968667 @default.
• W3099006076 cites W1984698679 @default.
• W3099006076 cites W1990159126 @default.
• W3099006076 cites W2026792308 @default.
• W3099006076 cites W2034361293 @default.
• W3099006076 cites W2059815385 @default.
• W3099006076 cites W2067529280 @default.
• W3099006076 cites W2076730692 @default.
• W3099006076 cites W2092804499 @default.
• W3099006076 cites W2115779459 @default.
• W3099006076 cites W2120677840 @default.
• W3099006076 cites W2120940824 @default.
• W3099006076 cites W2142225512 @default.
• W3099006076 cites W2150471053 @default.
• W3099006076 cites W2177704039 @default.
• W3099006076 cites W2244770355 @default.
• W3099006076 cites W2262231308 @default.
• W3099006076 cites W2271848631 @default.
• W3099006076 cites W2299192123 @default.
• W3099006076 cites W2343060669 @default.
• W3099006076 cites W2528228811 @default.
• W3099006076 cites W2754327139 @default.
• W3099006076 cites W2788562671 @default.
• W3099006076 cites W2803899323 @default.
• W3099006076 cites W2883673963 @default.
• W3099006076 cites W2896628407 @default.
• W3099006076 cites W2899809589 @default.
• W3099006076 cites W2954523493 @default.
• W3099006076 cites W2972664697 @default.
• W3099006076 cites W2975448357 @default.
• W3099006076 cites W2999817131 @default.
• W3099006076 cites W3026422528 @default.
• W3099006076 cites W3030566019 @default.
• W3099006076 cites W4250329983 @default.
• W3099006076 doi "https://doi.org/10.1016/j.ygyno.2020.10.034" @default.
• W3099006076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33190931" @default.
• W3099006076 hasPublicationYear "2021" @default.
• W3099006076 type Work @default.
• W3099006076 sameAs 3099006076 @default.
• W3099006076 citedByCount "4" @default.
• W3099006076 countsByYear W30990060762022 @default.
• W3099006076 countsByYear W30990060762023 @default.
• W3099006076 crossrefType "journal-article" @default.
• W3099006076 hasAuthorship W3099006076A5005358622 @default.
• W3099006076 hasAuthorship W3099006076A5014584195 @default.
• W3099006076 hasAuthorship W3099006076A5032378308 @default.
• W3099006076 hasAuthorship W3099006076A5043779387 @default.
• W3099006076 hasAuthorship W3099006076A5060953135 @default.
• W3099006076 hasAuthorship W3099006076A5079212572 @default.
• W3099006076 hasAuthorship W3099006076A5087865806 @default.
• W3099006076 hasConcept C118552586 @default.
• W3099006076 hasConcept C121608353 @default.
• W3099006076 hasConcept C126322002 @default.
• W3099006076 hasConcept C143998085 @default.
• W3099006076 hasConcept C144024400 @default.
• W3099006076 hasConcept C15744967 @default.
• W3099006076 hasConcept C190248442 @default.
• W3099006076 hasConcept C27415008 @default.
• W3099006076 hasConcept C2777179973 @default.
• W3099006076 hasConcept C2778087770 @default.
• W3099006076 hasConcept C2780427987 @default.
• W3099006076 hasConcept C36289849 @default.
• W3099006076 hasConcept C542102704 @default.
• W3099006076 hasConcept C71924100 @default.
• W3099006076 hasConcept C74196892 @default.
• W3099006076 hasConceptScore W3099006076C118552586 @default.
• W3099006076 hasConceptScore W3099006076C121608353 @default.
• W3099006076 hasConceptScore W3099006076C126322002 @default.
• W3099006076 hasConceptScore W3099006076C143998085 @default.
• W3099006076 hasConceptScore W3099006076C144024400 @default.
• W3099006076 hasConceptScore W3099006076C15744967 @default.
• W3099006076 hasConceptScore W3099006076C190248442 @default.
• W3099006076 hasConceptScore W3099006076C27415008 @default.
• W3099006076 hasConceptScore W3099006076C2777179973 @default.
• W3099006076 hasConceptScore W3099006076C2778087770 @default.
• W3099006076 hasConceptScore W3099006076C2780427987 @default.
• W3099006076 hasConceptScore W3099006076C36289849 @default.
• W3099006076 hasConceptScore W3099006076C542102704 @default.
• W3099006076 hasConceptScore W3099006076C71924100 @default.
• W3099006076 hasConceptScore W3099006076C74196892 @default.
• W3099006076 hasFunder F4320310151 @default.
• W3099006076 hasIssue "1" @default.
• W3099006076 hasLocation W30990060761 @default.
• W3099006076 hasOpenAccess W3099006076 @default.

• next